Novartis "one minute Maalox" TV ad OKed by NAD; beaker demo not supported.
This article was originally published in The Tan Sheet
Executive Summary
NOVARTIS "ONE MINUTE MAALOX" EFFICACY CLAIMS UPHELD BY NAD in a case report issued by the National Advertising Division of the Council of Better Business Bureaus April 6. "Novartis Consumer Health is pleased that the NAD has upheld the central message of our Maalox advertising: that Maalox starts to work on stomach acid in about one minute, whereas" J&J/Merck's Pepcid AC "takes considerably longer"; and "this difference is a major reason that hospitals give Maalox rather than Pepcid AC for heartburn," the company comments in the report.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
People In Brief
Perrigo promotes in pricing, planning
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Need a specific report? 1000+ reports available
Buy Reports
Register for our free email digests: